HCV Drug Therapy and the DNA Base Excision Repair System
The Influence of New Anti-HCV Therapy on the DNA Base Excision Repair System of Peripheral Blood Mononuclear Cells
The Prodrug Opportunity: Making Good Drugs Better
Elegance in Chemistry, Product Development, and Marketability
- INFOGRAPHIC: Spotlight on How a Discovery Program Was Born
Looking at the CAR-T Landscape as First Approval Nears
Sounds of Science Podcast
- 60 Clifford St.
- Providence RI, 02903
- UNITED STATES
Nabsys is working on enabling advances in life sciences and healthcare through strategic deployment of a novel positional sequencing platform with broad applicability for DNA analysis. The Nabsys DNA analysis platform employs fully solid state nanodetectors that reveal both the identity and location of DNA sequences over long distances (10’s to 100’s of thousands of bases). The technology employs electronic detection that permits the location of sequences to be identified in a highly accurate and rapid manner. This approach allows for the identification of sequence variants of all length scales applicable to diagnostics, agriculture and whole genome sequencing.